Telemedicine, which became a household term during the pandemic, is now a go-to option for many patients who prefer to avoid the hassle of doctor visits. Instead of driving to appointments or sitting in crowded waiting rooms, patients can easily get prescriptions and treatment recommendations and even check their vitals using connected devices from the comfort of home.
As the demand for these services keeps growing, investors could take a look at these three telemedicine stocks that are well-positioned to benefit from this trend and help make healthcare more accessible: Doximity, Inc. (DOCS), Hims & Hers Health, Inc. (HIMS), and GoodRx Holdings, Inc. (GDRX).
